| Region: | |
| Category: |
(1634 reports matching your criteria)
|
2013 U.S. Mental Health & Substance Abuse Centers Industry-Industry & Market Report
7/15/2013 | published by: Barnes Reports
... size of the industry (sales, establishments, employment) nationally and for all 50 U.S. States and over 900 metro areas. Other data include financial ratios, number of firms, payroll, industry definition, 5-year historical trends on industry ...
|
read more...
|
$149.00
|
|
Biotechnology Product Manufacturing
6/17/2013 | published by: First Research, Inc.
... Amgen, Biogen Idec, Genentech (owned by Switzerland-based Roche), and Monsanto; Cangene (Canada) and ADIMMUNE (Taiwan); and the biotech research arms of major international pharmaceutical companies such as Sanofi (France). The global biotechnology industry includes about ...
|
read more...
|
$129.00
|
|
Analysis of the Sexually-Transmitted Disease Testing Market in the US: Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, Syphilis
6/14/2013 | published by: Venture Planning Group
... emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers. The report presents detailed analysis of the STD market in the US, Current scientific views on epidemiology and etiology ...
|
read more...
|
$4,500.00
|
|
2013 Analysis of the US HIV/AIDS Diagnostics Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices—Supplier Shares and Sales Forecasts For Immunodiagnostic and NAT Procedures
6/14/2013 | published by: Venture Planning Group
... diagnostics market in the US. The report provides test volume and sales forecasts for HIV-1/2, HIV Ag, NAT, Western Blot and other confirmatory tests performed in the following market segments: - Hospitals - Commercial/Private Laboratories ...
|
read more...
|
$2,300.00
|
|
2013 Analysis of the US Hepatitis Diagnostics Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices--Supplier Shares and Sales Forecasts For 10 Immunodiagnostic and NAT Procedures
6/14/2013 | published by: Venture Planning Group
... Hepatitis diagnostics market in the US. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, ...
|
read more...
|
$3,900.00
|
|
Analysis of the Respiratory Disease Testing Market in the US: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis
6/14/2013 | published by: Venture Planning Group
... market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers. About this Report This report presents detailed analysis of the Respiratory Disease market in the US.Current scientific ...
|
read more...
|
$4,600.00
|
|
Advanced Wound Management Market to 2019 - Increasing Incidence of Diabetes Leading to Chronic Wounds in Emerging Countries will Drive Future Growth
6/3/2013 | published by: GBI Research
... of Diabetes Leading to Chronic Wounds in Emerging Countries will Drive Future Growth” looks at the market, competitive landscape, and trends for eight advanced wound dressing segments: foams, hydrocolloids, hydrogels, semi-permeable films, hydrofibers, wound contact ...
|
read more...
|
$3,500.00
|
|
US Non-Invasive Prenatal Diagnostics - Market Insight
6/1/2013 | published by: RNCOS
... health. The current invasive technologies such as CVS and amniocentesis that are used to detect chromosomal abnormalities pose serious risks of miscarriages and are being replaced by the non-invasive prenatal diagnostics technologies. Although NIPD is ...
|
read more...
|
$1,200.00
|
|
Canada Pharmaceuticals and Healthcare Report Q3 2013
5/29/2013 | published by: Business Monitor International
... during the economic downturn and indirectlycreated jobs for other sectors. It has also played an important role in contributing taxes and supportingother industries' growth. We believe that, with household consumption remaining subdued and the overalleconomy ...
|
read more...
|
$1,295.00
|
|
MediPoint: Breast Cancer Imaging - US Analysis and Market Forecasts
5/27/2013 | published by: GlobalData
... in men. The global incidence of breast cancer is increasing due to an increased lifespan and increasing adoption of western lifestyle risk factors. Early diagnosis of breast cancer is the foundation for increasing survival rates ...
|
read more...
|
$4,450.00
|
|
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - US
5/27/2013 | published by: GlobalData
... information and analysis on the healthcare, regulatory and reimbursement landscape of US. The report identifies the key trends in the healthcare market of US. The report also provides insights on the demographic, regulatory, reimbursement landscape ...
|
read more...
|
$1,995.00
|
|
Medicinal and Botanical Manufacturing Industry in the U.S. and its International Trade [2013 Q2 Edition]
5/20/2013 | published by: Supplier Relations US, LLC
... and downstream industries, and trade data. This 2013 report's 174 pages and over 150 charts and tables cover the domestic market, global market and overseas growth opportunities. Find the latest data on shipments, inventory, international ...
|
read more...
|
$599.00
|
|
Pharmaceutical Preparation Manufacturing Industry in the U.S. and its International Trade [2013 Q2 Edition]
5/20/2013 | published by: Supplier Relations US, LLC
... industries, and trade data. This 2013 report's 174 pages and over 150 charts and tables cover the domestic market, global market and overseas growth opportunities. Find the latest data on shipments, inventory, international trade, and ...
|
read more...
|
$799.00
|
|
Biological Product (except Diagnostic) Manufacturing Industry in the U.S. and its International Trade [2013 Q2 Edition]
5/20/2013 | published by: Supplier Relations US, LLC
... upstream and downstream industries, and trade data. This 2013 report's 169 pages and over 150 charts and tables cover the domestic market, global market and overseas growth opportunities. Find the latest data on shipments, inventory, ...
|
read more...
|
$599.00
|
|
Vaccine Market in Mexico
5/20/2013 | published by: Global Research & Data Services
... Market for vaccines by type Forecasts and future outlook of the market Macroeconomic indicators This market study answers to questions such as: What is the size of the vaccine market in Mexico? How is the ...
|
read more...
|
$653.00
|
|
Vaccine Market in United States
5/20/2013 | published by: Global Research & Data Services
... United States Market for vaccines by type Forecasts and future outlook of the market Macroeconomic indicators This market study answers to questions such as: What is the size of the vaccine market in United States? ...
|
read more...
|
$653.00
|
|
Vaccines - American Markets Package
5/20/2013 | published by: Global Research & Data Services
... vaccines in different American countries Market for vaccines by product type Forecasts and future outlook of the market Macroeconomic indicators These market studies answer to questions such as: What is the size of the vaccine ...
|
read more...
|
$5,180.11
|
|
Vaccine Market in Canada
5/20/2013 | published by: Global Research & Data Services
... Market for vaccines by type Forecasts and future outlook of the market Macroeconomic indicators This market study answers to questions such as: What is the size of the vaccine market in Canada? How is the ...
|
read more...
|
$653.00
|
|
ICT Spend Predictions in Large Mexican Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013
5/18/2013 | published by: Kable
... areas of enterprise ICT spend, namely hardware, software, IT services, telecommunications and consulting. Summary Why was the report written? This report presents the output from Kable’s ICT spend prediction statistical model, a log-linear regression model ...
|
read more...
|
$495.00
|
|
ICT Spend Predictions in Medium-sized Mexican Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013
5/18/2013 | published by: Kable
... areas of enterprise ICT spend, namely hardware, software, IT services, telecommunications and consulting. Summary Why was the report written? This report presents the output from Kable’s ICT spend prediction statistical model, a log-linear regression model ...
|
read more...
|
$495.00
|
|
ICT Spend Predictions in Small Mexican Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013
5/18/2013 | published by: Kable
... areas of enterprise ICT spend, namely hardware, software, IT services, telecommunications and consulting. Summary Why was the report written? This report presents the output from Kable’s ICT spend prediction statistical model, a log-linear regression model ...
|
read more...
|
$495.00
|
|
ICT Spend Predictions in Medium-sized US Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013
5/17/2013 | published by: Kable
... areas of enterprise ICT spend, namely hardware, software, IT services, telecommunications and consulting. Summary Why was the report written? This report presents the output from Kable’s ICT spend prediction statistical model, a log-linear regression model ...
|
read more...
|
$495.00
|
|
ICT Spend Predictions in Small US Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013
5/17/2013 | published by: Kable
... areas of enterprise ICT spend, namely hardware, software, IT services, telecommunications and consulting. Summary Why was the report written? This report presents the output from Kable’s ICT spend prediction statistical model, a log-linear regression model ...
|
read more...
|
$495.00
|
|
ICT Spend Predictions in Large Canadian Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013
5/17/2013 | published by: Kable
... areas of enterprise ICT spend, namely hardware, software, IT services, telecommunications and consulting. Summary Why was the report written? This report presents the output from Kable’s ICT spend prediction statistical model, a log-linear regression model ...
|
read more...
|
$495.00
|
|
ICT Spend Predictions in Medium-sized Canadian Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013
5/17/2013 | published by: Kable
... areas of enterprise ICT spend, namely hardware, software, IT services, telecommunications and consulting. Summary Why was the report written? This report presents the output from Kable’s ICT spend prediction statistical model, a log-linear regression model ...
|
read more...
|
$495.00
|